产品介绍：
产品说明
一般描述
This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.
生化/生理作用
阿糖胞苷复合到 DNA 中后，可通过与导致 DNA 断裂的拓扑异构酶 I 形成可裂解复合物而抑制 DNA 的复制，但不会抑制 RNA 的合成。抗白血病制剂。
包装
Unit quantity: 100 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity please visit British Pharmacopoeia
其他说明
Sales restrictions may apply.
基本信息
| 经验(实验)分子式 | C9H13N3O5 |
| 分子量 | 243.22 |
| Beilstein | 89175 |
| MDL编号 | MFCD00066487 |
产品性质
| 等级 | pharmaceutical primary standard |
| manufacturer/tradename | BP |
| 格式 | neat |
| 储存温度 | 2-8℃ |
| SMILES string | NC1=NC(=O)N(C=C1)[C@@H]2O[C@H](CO)[C@@H](O)[C@@H]2O |
| InChI | 1S/C9H13N3O5/c10-5-1-2-12(9(16)11-5)8-7(15)6(14)4(3-13)17-8/h1-2,4,6-8,13-15H,3H2,(H2,10,11,16)/t4-,6-,7+,8-/m1/s1 |
| InChI key | UHDGCWIWMRVCDJ-CCXZUQQUSA-N |
| Gene Information | human ... POLA1(5422), POLA2(23649), POLD1(5424), POLD2(5425), POLD3(10714), POLD4(57804), POLE(5426), POLE2(5427), POLE3(54107), PRIM1(5557), PRIM2(5558) |
安全信息
| 象形图 |   |
| 警示用语： | Warning |
| 危险声明 | H317 - H361fd |
| 预防措施声明 | P202 - P261 - P272 - P280 - P302 + P352 - P308 + P313 |
| 危险分类 | Repr. 2 - Skin Sens. 1 |
| 储存分类代码 | 11 - Combustible Solids |
| WGK | WGK 3 |
| 闪点(F) | Not applicable |
| 闪点(C) | Not applicable |
